Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-07-16

Clinical Trial Update: Ketamine in the Treatment of Depression [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on ketamine for treating major depressive disorder; results completed and posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketamine (ketamine)

Snippet

Sponsor: Columbia University | Conditions: Major Depressive Disorder | Phase 2 | Status: COMPLETED | Results posted: 2019-07-16